Choosing the safest GLP-1 for you requires matching medication type to your medical situation and tolerance threshold
All medications come from licensed 503A compounding pharmacies, guaranteeing pharmaceutical-grade purity and potency
Additionally, there are more injectable biosimilars and generics being developed by drug manufacturers because of the ease in their regulatory pathway and delivery system through prefilled pens
In clinical trials it is being investigated for obesity and overweight with weight-related conditions, type 2 diabetes, knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
279 In preclinical studies, GLP-1 RAs reduce amyloid- deposition, attenuate tau phosphorylation, and suppress microglial activation